Video

A Smile Could Mean the World to Someone With Cancer

Author(s):

Jim Kelly, NFL Hall of Famer, discusses how much a smile or a kind word can mean to someone with cancer – and he knows from experience.

Jim Kelly, NFL Hall of Famer, discusses how much a smile or a kind word can mean to someone with cancer — and he knows from experience.

Kelly was diagnosed with squamous cell carcinoma in 2013 and, after a complete removal of his upper jaw, faced a recurrence in 2014. However, when he was in the hospital and nurses, caregivers and friends visited him with kinds words, hugs and well wishes, his spirits were lifted. Now, inspiring others —as others encouraged him – is what keeps him going. After all, nobody knows what tomorrow holds.

Related Videos
Image of bald man.
Dr. Tycel Phillips is an Associate Professor in the Division of Lymphoma, Department of Hematology and Hematopoietic Cell Transplantation, at City of Hope in Duarte, California.
Image of Dr. Salani.
Dr. Debu Tripathy is a professor and chairman of the Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, in Houston, and the editor-in-chief of CURE®.
Dr. Suneel Kamath is an assistant professor of medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, in Ohio.
Image of Dr. Fakih.
Dr. Catherine Wu is chief of the Division of Stem Cell Transplantation and Cellular Therapies at Dana-Farber Cancer Institute, and institute member at the Broad Institute of MIT and Harvard, in Boston, Massachusetts.
Dr. John Oertle discusses the key benefits to come from patients with cancer connecting with support networks, advocacy groups and resources.
Dr. Gabriel A. Brooks discussed the recent FDA product labeling update for Xeloda and 5-FU.
Dr. Alan Tan is the GU Oncology Lead at the Vanderbilt-Ingram Cancer Center in Nashville, Tennessee, as well as an associate professor in the Division of Hematology/Oncology at Vanderbilt University Medical Center and GU Executive Officer with the Alliance for Clinical Trials in Oncology.